Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.56 |
| ▸ | NAAA | Q02083 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7780347 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL7775113 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL7781974 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL27754415 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL7781972 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL7350344 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL794471 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL7050366 | 1.00 | NOD1 (0.56) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL28155523 | 0.98 | NOD1 (0.55) | NOD1NAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL2732561 | 0.98 | NOD1 (0.54) | NOD1NAAAHTR2CPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492222-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | NUTRIVERT INC. (US) | 2025-12-09 | — | — | US | claimed |
| EP-4126040-B1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT INC (US) | 2025-02-19 | — | — | EP | claimed |
| US-20230174577-A1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT LLC (US) | 2023-06-08 | — | — | US | claimed |
| CN-115605226-A | Lipophilic enantiomer of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | 纽特莱特公司（US） | 2023-01-13 | — | — | CN | claimed |
| US-12492222-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | NUTRIVERT INC. (US) | 2025-12-09 | — | — | US | disclosed |
| EP-4126040-B1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT INC (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2025006896-A1 | LOW DOSE MURAMYL DIPEPTIDE ANALOGUE-CONTAINING COMPOSITIONS AND METHODS OF USING SAME FOR IMMUNOPROTECTION | NUTRIVERT INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| US-20230174577-A1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | NUTRIVERT LLC (US) | 2023-06-08 | — | — | US | disclosed |
| CN-115605226-A | Lipophilic enantiomer of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | 纽特莱特公司（US） | 2023-01-13 | — | — | CN | disclosed |
| EP-1135398-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | Monsanto Technology LLC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-6218563-B1 | Cyanophosphonamides and method for preparation | MONSANTO COMPANY | 2001-04-17 | — | — | US | disclosed |
| WO-2000032611-A1 | CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION | MONSANTO TECHNOLOGY LLC (US) | 2000-06-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230174577-A1 | LIPOPHILIC ENANTIOMERS OF DESACETYLGLUCOSAMINE MURAMYL DIPEPTIDE WITH ANTI-INFLAMMATORY AND GROWTH PROMOTING ACTIVITY | MIF, DNPEP, GLMN | NOD1 110/4885NAAA 485/4885HTR2C 4362/4885 |
| US-12492222-B2 | Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity | MIF, DNPEP, GLMN | NOD1 110/4885NAAA 485/4885HTR2C 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.